Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Public ClinicalTrials.gov record NCT05049057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Treatment of Acute Post-Traumatic Headache With Erenumab 140 mg, Military Service Members and Civilians With Mild TBI: A Randomized, Double Blind, Placebo Controlled, Multicenter 12-week Duration Study Followed by a 4-week Open-Label Safety Extension
Study identification
- NCT ID
- NCT05049057
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Other
- Enrollment
- 404 participants
Conditions and interventions
Interventions
- Erenumab 140 Mg/mL Subcutaneous Solution Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 18, 2022
- Primary completion
- May 18, 2026
- Completion
- May 18, 2027
- Last update posted
- Feb 21, 2024
2022 – 2027
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Womack Army Medical Center - Fort Liberty | Fort Bragg | North Carolina | 28310 | Recruiting |
| University of Pittsburgh Concussion Research Laboratory | Pittsburgh | Pennsylvania | 15203 | Not yet recruiting |
| William Beaumont Army Medical Center | El Paso | Texas | 79918 | Recruiting |
| Madigan Army Medical Center | Tacoma | Washington | 98431 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05049057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2024 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05049057 live on ClinicalTrials.gov.